A PROSPECTIVE STUDY ON COPING STRATEGIES AND QUALITY OF LIFE IN PATIENTS AFTER STROKE, ASSESSING PROGNOSTIC RELATIONSHIPS AND ESTIMATES OF COST-EFFECTIVENESS

被引:30
|
作者
Darlington, Anne-Sophie E. [2 ]
Dippel, Diederik W. J. [1 ]
Ribbers, Gerard M. [3 ,4 ]
van Balen, Romke [5 ]
Passchier, Jan [2 ]
Busschbach, Jan J. V. [2 ,6 ]
机构
[1] Erasmus MC, Dept Neurol, Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Med Psychol & Psychotherapy, Erasmus MC, NL-3015 GE Rotterdam, Netherlands
[3] Erasmus MC, Rijndam Rehabil Ctr, Rotterdam, Netherlands
[4] Erasmus MC, Dept Rehabil Med, Rotterdam, Netherlands
[5] Antonius Binnenweg Nursing Home & Geriatr Ctr, Rotterdam, Netherlands
[6] Viersprong Inst Studies Personal Disorders, Halsteren, Netherlands
关键词
cost-effectiveness; stroke; quality of life; coping; PROBLEM-SOLVING THERAPY; CARE; PREVENTION; HANDICAP; EUROQOL; NICE;
D O I
10.2340/16501977-0313
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To examine the prognostic value of coping strategies of patients after stroke at time of discharge on quality of life approximately one year later. In addition, we estimated the maximum cost of improving quality of life by enhancing coping strategies using strict assumptions. Methods: Eighty patients with a stroke completed several questionnaires, at discharge to home and 9-12 months later (follow-up). Questionnaires measured quality of life, coping strategies Tenacious Goal Pursuit and Flexible Goal Adjustment. First, a regression analysis was carried out predicting quality of life at follow-up from coping strategies at discharge. Secondly, a maximum in terms of acceptable cost was calculated for several possible effect sizes. Results: Both coping strategies at discharge were positively associated with quality of life at follow-up. With regards to cost-effectiveness, a medium effect size would result in an increase in quality of life of approximately 10%. The maximum acceptable cost of an intervention for a single patient is therefore set at (sic)2500, assuming a benefit of one year and a cost per quality adjusted life year of (sic)25,000. Conclusion: Coping strategies at discharge are predictive of quality of life one year later. The costs of improving quality of life are thought to be within the limits that determine a cost-effective intervention.
引用
收藏
页码:237 / 241
页数:5
相关论文
共 50 条
  • [41] QUALITY OF LIFE AND UTILITY VALUES FOR COST-EFFECTIVENESS MODELING IN JAPANESE PATIENTS WITH TYPE 2 DIABETES
    Crawford, B.
    Ishii, H.
    Takamura, H.
    Nishioka, Y.
    Langer, J.
    Watanabe, M.
    Kim, H. R.
    VALUE IN HEALTH, 2018, 21 : S139 - S139
  • [42] Quality of Life and Utility Values for Cost-Effectiveness Modeling in Japanese Patients with Type 2 Diabetes
    Ishii, Hitoshi
    Takamura, Hiroshi
    Nishioka, Yuichi
    Langer, Jakob
    Watanabe, Michihisa
    Kim, Hyunchung Ray
    Crawford, Bruce
    DIABETES THERAPY, 2020, 11 (12) : 2931 - 2943
  • [43] Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis
    Sawaya, George F.
    Sanstead, Erinn
    Alarid-Escudero, Fernando
    Smith-McCune, Karen
    Gregorich, Steven E.
    Silverberg, Michael J.
    Leyden, Wendy
    Huchko, Megan J.
    Kuppermann, Miriam
    Kulasingam, Shalini
    JAMA INTERNAL MEDICINE, 2019, 179 (07) : 867 - 878
  • [44] Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes
    M. J. Hassett
    H. Li
    H. J. Burstein
    R. S. Punglia
    Breast Cancer Research and Treatment, 2020, 181 : 43 - 51
  • [45] Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes
    Hassett, M. J.
    Li, H.
    Burstein, H. J.
    Punglia, R. S.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (01) : 43 - 51
  • [46] Cost-Effectiveness of Different Strategies for Stroke Prevention in Patients with Atrial Fibrillation in a Health Resource-Limited Setting
    Wu, Bin
    Kun, Li
    Liu, Xiaoyan
    He, Ben
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (01) : 87 - 98
  • [47] FOLLOWPACE study: a prospective study on the cost-effectiveness of routine follow-up visits in patients with a pacemaker
    van Eck, JWM
    van Hemel, NM
    Grobbee, DE
    Buskens, E
    Moons, KGM
    EUROPACE, 2006, 8 (01): : 60 - 64
  • [48] CHALLENGES IN ASSESSING COST-EFFECTIVENESS OF THERAPIES FOR DIALYSIS PATIENTS: A CASE STUDY OF SEVELAMER FOR THE TREATMENT OF HYPERPHOSPHATEMIA
    Grima, D.
    Mendelssohn, D.
    Airia, P.
    Dunn, E.
    Bernard, L.
    VALUE IN HEALTH, 2010, 13 (03) : A78 - A78
  • [49] COST-EFFECTIVENESS OF COMPUTED-TOMOGRAPHY IN PATIENTS WITH STROKE - MULTI-CENTER RETROSPECTIVE STUDY
    PODHORODECKI, A
    HRYHOROWYCH, A
    MARCH, H
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1985, 66 (08): : 561 - 561
  • [50] Coping strategies and quality of life in patients with central centrifugal cicatricial alopecia: a survey study
    Ogbutor, Chino
    Ezemma, Ogechi
    Chen, Li-Chi
    Taylor, Susan C.
    Aguh, Crystal
    McMichael, Amy
    Devjani, Shivali
    Kelley, Kristen J.
    Senna, Maryanne
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (10) : 1464 - 1466